Biologically Active Small Molecules

An oxidation product of AA synthesized by human platelets and Aplaysia nervous tissue.

An oxidation product of AA synthesized by human platelets and Aplaysia nervous tissue.

An oxidation product of AA synthesized by human platelets and Aplaysia nervous tissue.

An oxidation product of AA synthesized by human platelets and Aplaysia nervous tissue.

A FAHFA in which palmitic acid occurs at the 12-position on hydroxy stearic acid present at 2- to 3-fold higher levels in adipose tissue of AG4OX mice compared to wild type and in fasted wild-type mice compared to fed levels are reduced upon

A FAHFA in which palmitic acid occurs at the 12-position on hydroxy stearic acid present at 2- to 3-fold higher levels in adipose tissue of AG4OX mice compared to wild type and in fasted wild-type mice compared to fed levels are reduced upon

A FAHFA in which palmitic acid occurs at the 12-position on hydroxy stearic acid present at 2- to 3-fold higher levels in adipose tissue of AG4OX mice compared to wild type and in fasted wild-type mice compared to fed levels are reduced upon

An internal standard for the quantification of 12-PAHSA by GC- or LC-MS.

An internal standard for the quantification of 12-PAHSA by GC- or LC-MS.

An internal standard for the quantification of 12-PAHSA by GC- or LC-MS.

An internal standard for the quantification of 12-PAHSA by GC- or LC-MS.

A FAHFA consisting of palmitoleic acid esterified at the 12th carbon of stearic acid significantly elevated in serum of glucose tolerant AG4OX mice may be a bioactive lipid with roles in metabolic syndrome and inflammation.